10.1172/JCI34599 259 TangF.BarbacioruC.WangY.NordmanE.LeeC.XuN.et al (2009)
There were no attempts to conduct a meta-analysis or systematic review
Despite its devastating impact, sepsis-associated brain dysfunction (SABD) is often overlooked, with approximately 70% of sepsis patients developing neurological complications such as impaired consciousness, cognitive decline, and altered mental status [4]
Stack #6: GHK-Cu + BPC-157 (Skin/repair stack) Why its popular: This is a regeneration aesthetic stack: hair, skin, collagen, wound healing, plus systemic repair. The regulatory nuance most people miss In the FDAs September 2024 update, GHK-Cu appears with a specific note: it is listed under Category 1 except for injectable routes, while injectable routes are listed under Category 2
Despite being used locally (e.g.,injected near the injury site), BPC-157 seems to exert full-body effects
GHK-Cu Research Overview In published preclinical literature, GHK-Cu has been investigated for its role in copper transport, collagen and glycosaminoglycan synthesis in fibroblast models, extracellular-matrix remodeling, and broad gene-expression modulation